The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
Open accessAbstract
Multiple independent genomic profiling efforts have recently identified clinically and molecularly distinct subgroups of ependymoma arising from all three anatomic compartments of the central nervous system (supratentorial brain, posterior fossa, and spinal cord). These advances motivated a consensus meeting to discuss: (1) the utility of current histologic grading criteria, (2) the integration of molecular-based stratification schemes in future clinical trials for patients with ependymoma and (3) current therapy in the context of molecular subgroups. Discussion at the meeting generated a series of consensus statements and recommendations from the attendees, which comment on the prognostic evaluation and treatment decisions of patients with intracranial ependymoma (WHO Grade II/III) based on the knowledge of its molecular subgroups. The major consensus among attendees was reached that treatment decisions for ependymoma (outside of clinical trials) should not be based on grading (II vs III). Supratentorial and posterior fossa ependymomas are distinct diseases, although the impact on therapy is still evolving. Molecular subgrouping should be part of all clinical trials henceforth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Self-citationThe 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Pajtler, K. W., Witt, H., Sill, M., Jones, D. T. W., Hovestadt, V., Kratochwil, F., Wani, K., Tatevossian, R., Punchihewa, C., Johann, P., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.002 · Cited by 1,225
Self-citationRadial glia cells are candidate stem cells of ependymoma
Taylor, M. D., Poppleton, H., Fuller, C., Su, X., Liu, Y., Jensen, P., Magdaleno, S., Dalton, J., Calabrese, C., Board, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.001 · Cited by 829
Self-citationC11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
Parker, M., Mohankumar, K. M., Punchihewa, C., Weinlich, R., Dalton, J. D., Li, Y., Lee, R., Tatevossian, R. G., Phoenix, T. N., Thiruvenkatam, R., et al. (2014) · Nature · doi:10.1038/nature13109 · Cited by 670
Self-citationEpigenomic alterations define lethal CIMP-positive ependymomas of infancy
Mack, S. C., Witt, H., Piro, R. M., Gu, L., Zuyderduyn, S., Stütz, A. M., Wang, X., Gallo, M., Garzia, L., Zayne, K., et al. (2014) · Nature · doi:10.1038/nature13108 · Cited by 607
Self-citationDelineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Witt, H., Mack, S. C., Ryzhova, M., Bender, S., Sill, M., Isserlin, R., Benner, A., Hielscher, T., Milde, T., Remke, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.007 · Cited by 559
Self-citationConformal radiotherapy after surgery for paediatric ependymoma: a prospective study
Merchant, T. E., Li, C., Xiong, X., Kun, L. E., Boop, F. A., & Sanford, R. A. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70342-5 · Cited by 510
Self-citationCross-species genomics matches driver mutations and cell compartments to model ependymoma
Johnson, R. A., Wright, K. D., Poppleton, H., Mohankumar, K. M., Finkelstein, D., Pounds, S. B., Rand, V., Leary, S. E. S., White, E., Eden, C., et al. (2010) · Nature · doi:10.1038/nature09173 · Cited by 367
Self-citationEllison, D. W., Kocak, M., Figarella-Branger, D., Felice, G., Catherine, G., Pietsch, T., Frappaz, D., Massimino, M., Grill, J., Boyett, J. M., et al. (2011) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-10-7 · Cited by 308
Self-citationRamaswamy, V., Hielscher, T., Mack, S. C., Lassaletta, A., Lin, T., Pajtler, K. W., Jones, D. T. W., Luu, B., Cavalli, F. M. G., Aldape, K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7825 · Cited by 206
Self-citationC11ORF95-RELA FUSIONS DRIVE ONCOGENIC NF-KB SIGNALING IN EPENDYMOMA
Gilbertson, R., Parker, M., Mohankumar, K. M., Punchihewa, C., Weinlich, R., Dalton, J. D., Li, Y., Lee, R., Tatevossian, R. G., Phoenix, T. N., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.57 · Cited by 173
Self-citationA prognostic gene expression signature in infratentorial ependymoma
For the Collaborative Ependymoma Research Network, Wani, K., Armstrong, T. S., Vera-Bolanos, E., Raghunathan, A., Ellison, D., Gilbertson, R., Vaillant, B., Goldman, S., Packer, R. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0941-4 · Cited by 162
Self-citationMacDonald, S. M., Sethi, R., Lavally, B. L., Yeap, B. Y., Marcus, K. J., Caruso, P. A., Pulsifer, M., Huang, M., Ebb, D. H., Tarbell, N. J., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not121 · Cited by 150
Kilday, J., Mitra, B., Domerg, C., Ward, J. H., Andreiuolo, F. D. M., Osteso-Ibáñez, T., Mauguen, A., Varlet, P., Deley, M. L., Lowe, J. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2489 · Cited by 141
Self-citationSurvival Benefit for Pediatric Patients With Recurrent Ependymoma Treated With Reirradiation
Bouffet, É., Hawkins, C. E., Ballourah, W., Taylor, M. D., Bartels, U. K., Schoenhoff, N. J., Tsangaris, E., Huang, A., Kulkarni, A. V., Mabbott, D., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.039 · Cited by 140
Self-citationGarvin, J. H., Selch, M. T., Holmes, E., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24274 · Cited by 123
Chemotherapy for intracranial ependymomas
Bouffet, É., & Foreman, N. K. (1999) · Child s Nervous System · doi:10.1007/s003810050544 · Cited by 120
Self-citationAn Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma
Atkinson, J. M., Shelat, A. A., Carcaboso, A. M., Kranenburg, T. A., Arnold, L. A., Boulos, N., Wright, K. D., Johnson, R. A., Poppleton, H., Mohankumar, K. M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.013 · Cited by 120
Self-citationYu, L., Baxter, P. A., Voicu, H., Gurusiddappa, S., Zhao, Y., Adesina, A. M., Man, T., Shu, Q., Zhang, Y.-J., Zhao, X.-M., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop056 · Cited by 104
Milde, T., Kleber, S., Korshunov, A., Witt, H., Hielscher, T., Koch, P., Kopp, H., Jugold, M., Deubzer, H. E., Oehme, I., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0866-3 · Cited by 94
Self-citationAn in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes
Mohankumar, K. M., Currle, D. S., White, E. L., Boulos, N., Dapper, J. D., Eden, C. O., Nimmervoll, B. V., Thiruvenkatam, R., Connelly, M., Kranenburg, T. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3323 · Cited by 85
Self-citationSupratentorial ependymoma in children: To observe or to treat following gross total resection?
Venkatramani, R., Dhall, G., Patel, M., Grimm, J., Hawkins, C. E., McComb, J. G., Krieger, M. D., Wong, K., O’Neil, S., & Finlay, J. L. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23086 · Cited by 42
Self-citationTelomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
Barszczyk, M., Buczkowicz, P., Castelo‐Branco, P., Mack, S. C., Ramaswamy, V., Mangerel, J., Agnihotri, S., Remke, M., Golbourn, B. J., Pajovic, S., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1327-6 · Cited by 38
Self-citationRand, V., Prebble, E., Ridley, L., Howard, M., Wei, W., Bründler, M.-A., Fee, B. E., Riggins, G. J., Coyle, B., & Grundy, R. G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604651 · Cited by 36
Self-citationPhase I study of 5-fluorouracil in children and young adults with recurrent ependymoma
Wright, K. D., Daryani, V. M., Turner, D. C., Onar‐Thomas, A., Boulos, N., Orr, B. A., Gilbertson, R. J., Stewart, C. F., & Gajjar, A. J. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov181 · Cited by 33
Self-citationTreatment and survival of supratentorial and posterior fossa ependymomas in adults
Nuño, M., Yu, J. J., Varshneya, K., Alexander, J. E., Mukherjee, D. R., Black, K. L., & Patil, C. G. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.11.014 · Cited by 24
Emerging Insights into the Ependymoma Epigenome
Mack, S. C., Witt, H., Wang, X., Milde, T., Yao, Y., Bertrand, K. C., Korshunov, A., Pfister, S. M., & Taylor, M. D. (2013) · Brain Pathology · doi:10.1111/bpa.12020 · Cited by 22
Self-citation
Cited by
Primary brain tumours in adults
Lapointe, S., Perry, A., & Butowski, N. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30990-5 · Cited by 1,366
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,271
Challenges to curing primary brain tumours
Aldape, K., Brindle, K. M., Chesler, L., Chopra, R., Gajjar, A., Gilbert, M. R., Gottardo, N., Gutmann, D. H., Hargrave, D., Holland, E. C., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0177-5 · Cited by 959
Self-citationWHO 2016 Classification of gliomas
Wesseling, P., & Capper, D. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12432 · Cited by 795
Louis, D. N., Wesseling, P., Aldape, K., Brat, D. J., Capper, D., Cree, I. A., Eberhart, C., Figarella‐Branger, D., Fouladi, M., Fuller, G. N., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12832 · Cited by 525
Self-citation
Metadata
- Authors
- Pajtler, K. W., Mack, S. C., Ramaswamy, V., Smith, C. A., Witt, H., Smith, A., Hansford, J. R., von Hoff, K., Wright, K. D., Hwang, E., Frappaz, D., Kanemura, Y., Massimino, M., Faure-Conter, C., Modena, P., Tabori, U., Warren, K. E., Holland, E. C., Ichimura, K., Giangaspero, F., Castel, D., von Deimling, A., Kool, M., Dirks, P. B., Grundy, R. G., Foreman, N. K., Gajjar, A., Korshunov, A., Finlay, J., Gilbertson, R. J., Ellison, D. W., Aldape, K. D., Merchant, T. E., Bouffet, E., Pfister, S. M., & Taylor, M. D.
- Venue
- Acta Neuropathologica
- Published
- 2016-11-17
- Volume
- 133
- Issue
- 1
- Pages
- 5-12
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2553451383
- Cited by
- 337
- References
- 28
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.